Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer.

[1]  B. Baradaran,et al.  Overcoming trastuzumab resistance in HER2‐positive breast cancer using combination therapy , 2020, Journal of cellular physiology.

[2]  Sahar Barzegari Banadkoki,et al.  Optimization of induction parameters, structure quality assessment by ATR-FTIR and in silico characterization of expressed recombinant polcalcin in three different strains of Escherichia coli. , 2019, International journal of biological macromolecules.

[3]  S. Russell,et al.  Oncolytic Viruses: Priming Time for Cancer Immunotherapy , 2019, BioDrugs.

[4]  M. Karimi,et al.  Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy , 2019, Journal of cellular physiology.

[5]  Gul-e-Saba Chaudhry,et al.  Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics , 2019, Advanced pharmaceutical bulletin.

[6]  Sajini D Hettiarachchi,et al.  Nanoparticle-mediated targeted drug delivery for breast cancer treatment. , 2019, Biochimica et biophysica acta. Reviews on cancer.

[7]  Vanessa M. Hubbard-Lucey,et al.  Immunotherapy and targeted therapy combinations in metastatic breast cancer. , 2019, The Lancet. Oncology.

[8]  Bhaswati Chatterjee.  Animal Venoms have Potential to Treat Cancer. , 2019, Current topics in medicinal chemistry.

[9]  Eric P. Winer,et al.  Breast Cancer Treatment: A Review , 2019, JAMA.

[10]  Binchun Li,et al.  High-yield expression in Escherichia coli, biophysical characterization, and biological evaluation of plant toxin gelonin , 2019, 3 Biotech.

[11]  Massimo Libra,et al.  Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium , 2018, Front. Pharmacol..

[12]  B. Behnam,et al.  Potential Anticancer Activity of Caspian Cobra Venom Through Induction of Oxidative Stress in Glioblastoma Cell Line , 2018, Proceedings of the National Academy of Sciences, India Section B: Biological Sciences.

[13]  Yao Lin,et al.  Snake Venoms in Cancer Therapy: Past, Present and Future , 2018, Toxins.

[14]  F. Ribeiro,et al.  Animal Toxins as Therapeutic Tools to Treat Neurodegenerative Diseases , 2018, Front. Pharmacol..

[15]  H. Vatanpour,et al.  Naja Naja Oxiana Venom Fraction Selectively Induces ROS-Mediated Apoptosis in Human Colorectal Tumor Cells by Directly Targeting Mitochondria , 2017, Asian Pacific journal of cancer prevention : APJCP.

[16]  S. Attarde,et al.  Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines , 2017, BMC Complementary and Alternative Medicine.

[17]  C. Rapôso.  Scorpion and spider venoms in cancer treatment: state of the art, challenges, and perspectives , 2017, Journal of clinical and translational research.

[18]  D. Ribatti,et al.  The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein , 2017, Toxicon : official journal of the International Society on Toxinology.

[19]  Patrick C. Brennan,et al.  Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence , 2016, Breast Cancer Research and Treatment.

[20]  H. Vatanpour,et al.  Anticancer Activity a of Caspian Cobra (Naja naja oxiana) snake Venom in Human Cancer Cell Lines Via Induction of Apoptosis , 2016, Iranian journal of pharmaceutical research : IJPR.

[21]  I. Shrivastava,et al.  Naja naja oxiana Cobra Venom Cytotoxins CTI and CTII Disrupt Mitochondrial Membrane Integrity: Implications for Basic Three-Fingered Cytotoxins , 2015, PloS one.

[22]  A. Donald,et al.  Characterising the secondary structure changes occurring in high density systems of BLG dissolved in aqueous pH 3 buffer , 2015 .

[23]  K. Ebrahim,et al.  Anticancer Activity of Cobra Venom Polypeptide, Cytotoxin-II, against Human Breast Adenocarcinoma Cell Line (MCF-7) via the Induction of Apoptosis , 2014, Journal of breast cancer.

[24]  A. Gomes,et al.  Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice. , 2014, Current drug delivery.

[25]  L. A. Calderon,et al.  Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy , 2014, BioMed research international.

[26]  S. Kazarian,et al.  Recent applications of ATR FTIR spectroscopy and imaging to proteins. , 2013, Biochimica et biophysica acta.

[27]  M. F. Fernandes-Pedrosa,et al.  Toxins from Venomous Animals: Gene Cloning, Protein Expression and Biotechnological Applications , 2013 .

[28]  A. Gomes,et al.  Cytotoxic and antioxidant property of a purified fraction (NN-32) of Indian Naja naja venom on Ehrlich ascites carcinoma in BALB/c mice. , 2011, Toxicon : official journal of the International Society on Toxinology.

[29]  A. Saha,et al.  A lethal cardiotoxic-cytotoxic protein from the Indian monocellate cobra (Naja kaouthia) venom. , 2010, Toxicon : official journal of the International Society on Toxinology.

[30]  R. Rudolph,et al.  Recombinant production of bioactive human TNF-alpha by SUMO-fusion system--high yields from shake-flask culture. , 2010, Protein expression and purification.

[31]  R. Kontermann,et al.  Bispecific Antibodies for Cancer Immunotherapy , 2010, BioDrugs.

[32]  Liangyu Zhang,et al.  ACTX-8, a cytotoxic L-amino acid oxidase isolated from Agkistrodon acutus snake venom, induces apoptosis in Hela cervical cancer cells. , 2007, Life sciences.

[33]  C. Chien,et al.  Up-regulation of Bax and endonuclease G, and down-modulation of Bcl-XL involved in cardiotoxin III-induced apoptosis in K562 cells , 2006, Experimental & Molecular Medicine.

[34]  D. M. Parkin,et al.  Use of Statistics to Assess the Global Burden of Breast Cancer , 2006, The breast journal.

[35]  Scott D Ramsey,et al.  Breast Cancer in Limited‐Resource Countries: Health Care Systems and Public Policy , 2006, The breast journal.

[36]  R. Lewis,et al.  Therapeutic potential of venom peptides , 2003, Nature Reviews Drug Discovery.

[37]  M. Ahn,et al.  Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah). , 1997, The international journal of biochemistry & cell biology.

[38]  S. Gasanov,et al.  Central Asian cobra venom cytotoxins-induced aggregation, permeability and fusion of liposomes. , 1989, General physiology and biophysics.

[39]  T. Panavas,et al.  SUMO fusion technology for enhanced protein production in prokaryotic and eukaryotic expression systems. , 2009, Methods in molecular biology.

[40]  N. Greenfield.  Using circular dichroism spectra to estimate protein secondary structure , 2007, Nature Protocols.